Leprosy Mailing List – December 31, 2020
Ref.: (LML) The Brazilian Public Health System (SUS) will offer clarithromycin for the treatment of resistant leprosy
From: Rodrigo Sena, Brasília, Brazil
_____________________________________________________________________________________________________________________________________________
Dear Pieter,
I am writing to disclose that Brazil will adopt clarithromycin for the treatment of drug-resistant leprosy.
I made a brief summary of the scientific and economic evidence studies, which supported the decision of the public health system in Brazil (SUS). (attached file).
We are honored to contribute.
Greetings,
Rodrigo Sena
National Leprosy Program of Brazil.
_________________________________________________________________________________________________________________________________________________
LML - S Deepak, B Naafs, S Noto and P Schreuder
LML blog link: http://leprosymailinglist.blogspot.it/
Contact: Dr Pieter Schreuder << editorlml@gmail.com
--You received this message because you are subscribed to the Google Groups "Leprosy Mailing List" group.
To unsubscribe from this group and stop receiving emails from it, send an email to leprosymailinglist+unsubscribe@googlegroups.com.
To view this discussion on the web, visit https://groups.google.com/d/msgid/leprosymailinglist/eee9c8fa-76ae-40f3-9c60-4ee379d057dfn%40googlegroups.com.
No comments:
Post a Comment